Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Patterns of care for women with ovarian cancer in the United States.

Muñoz KA, Harlan LC, Trimble EL.

J Clin Oncol. 1997 Nov;15(11):3408-15.

PMID:
9363873
2.

Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.

Winter-Roach BA, Kitchener HC, Lawrie TA.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD004706. doi: 10.1002/14651858.CD004706.pub4. Review. Update in: Cochrane Database Syst Rev. 2015;(12):CD004706.

3.

International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.

Trimbos JB, Parmar M, Vergote I, Guthrie D, Bolis G, Colombo N, Vermorken JB, Torri V, Mangioni C, Pecorelli S, Lissoni A, Swart AM; International Collaborative Ovarian Neoplasm 1; European Organisation for Research and Treatment of Cancer Collaborators-Adjuvant ChemoTherapy un Ovarian Neoplasm.

J Natl Cancer Inst. 2003 Jan 15;95(2):105-12.

PMID:
12529343
4.

International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer.

Colombo N, Guthrie D, Chiari S, Parmar M, Qian W, Swart AM, Torri V, Williams C, Lissoni A, Bonazzi C; International Collaborative Ovarian Neoplasm (ICON) collaborators.

J Natl Cancer Inst. 2003 Jan 15;95(2):125-32.

PMID:
12529345
5.

Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.

Trimbos JB, Vergote I, Bolis G, Vermorken JB, Mangioni C, Madronal C, Franchi M, Tateo S, Zanetta G, Scarfone G, Giurgea L, Timmers P, Coens C, Pecorelli S; EORTC-ACTION collaborators. European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm.

J Natl Cancer Inst. 2003 Jan 15;95(2):113-25.

PMID:
12529344
6.

Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.

Winter-Roach BA, Kitchener HC, Dickinson HO.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD004706. doi: 10.1002/14651858.CD004706.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;3:CD004706.

PMID:
19588360
7.

Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.

Winter-Roach BA, Kitchener HC, Dickinson HO.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004706. doi: 10.1002/14651858.CD004706.pub2. Review. Update in: Cochrane Database Syst Rev. 2009;(3):CD004706.

PMID:
19160239
8.

Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.

Lawrie TA, Winter-Roach BA, Heus P, Kitchener HC.

Cochrane Database Syst Rev. 2015 Dec 17;(12):CD004706. doi: 10.1002/14651858.CD004706.pub5. Review.

PMID:
26676202
9.

Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer.

Covens A, Carey M, Bryson P, Verma S, Fung Kee Fung M, Johnston M.

Gynecol Oncol. 2002 Apr;85(1):71-80. Review.

PMID:
11925123
10.

Long-term results and prognostic factors in patients with epithelial ovarian cancer.

Brun JL, Feyler A, Chêne G, Saurel J, Brun G, Hocké C.

Gynecol Oncol. 2000 Jul;78(1):21-7.

PMID:
10873404
11.

High-dose platinum chemotherapy in advanced ovarian cancer: a phase II study.

Bertelsen K, Bastholt L.

Gynecol Oncol. 1992 Jan;44(1):79-82.

PMID:
1730430
13.

Medical treatment of epithelial ovarian cancer.

González-Martín AJ.

Expert Rev Anticancer Ther. 2004 Dec;4(6):1125-43. Review.

PMID:
15606338
14.

A systematic overview of chemotherapy effects in ovarian cancer.

Högberg T, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):340-60. Review.

PMID:
11441940
15.

Medical therapy of advanced malignant epithelial tumours of the ovary.

Colombo N, Parma G, Bocciolone L, Franchi D, Sideri M, Maggioni A.

Forum (Genova). 2000 Oct-Dec;10(4):323-32. Review.

PMID:
11535983
16.

Racial disparities in the treatment of advanced epithelial ovarian cancer.

Howell EA, Egorova N, Hayes MP, Wisnivesky J, Franco R, Bickell N.

Obstet Gynecol. 2013 Nov;122(5):1025-32. doi: 10.1097/AOG.0b013e3182a92011.

17.

Early stage ovarian cancer: the Italian contribution to clinical research. An update.

Favalli G, Odicino F, Torri V, Pecorelli S.

Int J Gynecol Cancer. 2001;11 Suppl 1:12-9.

PMID:
11488997
18.

Trends in treatment of advanced epithelial ovarian cancer in the Medicare population.

Thrall MM, Gray HJ, Symons RG, Weiss NS, Flum DR, Goff BA.

Gynecol Oncol. 2011 Jul;122(1):100-6. doi: 10.1016/j.ygyno.2011.03.022. Epub 2011 Apr 15.

19.

Effect of radical cytoreductive surgery on omission and delay of chemotherapy for advanced-stage ovarian cancer.

Wright JD, Herzog TJ, Neugut AI, Burke WM, Lu YS, Lewin SN, Hershman DL.

Obstet Gynecol. 2012 Oct;120(4):871-81.

PMID:
22996105
20.

Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.

Akeson M, Zetterqvist BM, Dahllöf K, Brännström M, Horvath G.

Acta Obstet Gynecol Scand. 2008;87(12):1343-52. doi: 10.1080/00016340802495491.

PMID:
18951208

Supplemental Content

Support Center